Advertisement

Index by author

November 01, 1993; Volume 267,Issue 2

  1. Datz, F L

    1. Enrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.
      K A Morton, B J Jones, M H Sohn, F L Datz and R E Lynch
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 697-702;

  2. Dazzi, L

    1. Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.
      A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G Biggio
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;

  3. De Costa, B R

    1. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
      S D Comer, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H Woods
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 866-874;
    2. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
      S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H Woods
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;

  4. Desouza, A

    1. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
      D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H Wong
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;

  5. Diez Marques, M L

    1. Calcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.
      I Duque, M Rodriguez Puyol, P Ruiz, M Gonzalez-Rubio, M L Diéz Marques and D Rodriguez Puyol
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 612-616;

  6. Dillard, R D

    1. Bronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.
      P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A Silbaugh
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;

  7. Divish, B J

    1. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
      D M Pollock, B J Divish, J S Polakowski and T J Opgenorth
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 657-663;

  8. Drachman, D B

    1. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
      R W Kuncl, D B Drachman, R Adams and M Lehar
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 582-589;

  9. Drugge, E D

    1. Renovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.
      C P Bell-Quilley, Y S Lin, S D Hilchey, E D Drugge and J C McGiff
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 676-682;

  10. Duncia, J V

    1. EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.
      P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement